N. Nwana

Use of cluster analysis as translational pharmacogenomics tool for breast cancer guided therapy

N. Nwana, 2014 .

Applying Keystroke Biometrics for User Verification and Identification

C. Tappert, Sung-Hyuk Cha, M. Curtin, 2011 .

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

M. Schuler, D. Hong, A. Delmonte, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non–small-cell lung cancer (NSCLC): results from cohort 6 of the phase 2 GEOMETRY mono-1 study.

H. Groen, A. Mansfield, E. Smit, 2020 .

Capmatinib in patients with high-level MET-amplified advanced non–small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study.

H. Groen, T. Overbeck, E. Smit, 2020 .

Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.

A. Mansfield, J. Neal, R. Heist, 2023, Clinical lung cancer.